Making the difference with Philips Live Image Guidance

CIRSE International Congress 2015

September 26-30, Centro de Congresos de Lisboa, Lisbon, Portugal, Booth: #71

Making the difference with Philips Live Image Guidance, in tumor therapy

Join us at CIRSE 2015! Philips will showcase how we are making a difference with Live Image Guidance in vascular interventions and tumor therapy striving to improve outcomes and save lives.

With our Live Image Guidance we aim to remove barriers to safer, more effective, and more reproducible treatments.

Be inspired! Join our lunch symposium

If you are not able to join, no problem. Register and receive the recording after the event.

Join us at CIRSE 2015!
Philips booth: #71
Radiation Protection Pavilion booth: #8

Meet the experts

Philips OncoSuite is the world’s first solution for tumor embolization and percutaneous ablation procedures in interventional oncology. Its 3D Dual-Phase imaging and Live Image Guidance provides an enhanced visualization of tumor lesions and their feeding vessels¹,².

Together we make the difference in tumor therapy to improve patient outcomes. With our Live Image Guidance we aim to remove barriers to safer, effective, and reproducible minimally invasive treatments, delivering relevant clinical value where it’s needed most – at the point of patient treatment.

Philips lunch Symposium

Saturday, September 26ᵗʰ, 2015

Auditorium 6

13:00-14:00

Add to calendar

Update on Live Image Guidance in Interventional Oncology

Dr. Jeff Geschwind, Yale University, New Haven, CT, USA

Seeing where you embolize– Visibility of a novel radiopaque bead during image guided interventions - an animal model

Dr. Karun Sharma, Cincinnati Children's Hospital, Cincinnati, OH, USA

Improved intraprocedural depiction of primary and secondary liver tumors: 3D HQ Imaging with Dual-Phase XperCT Open

Dr. Ruediger Schernthaler, Medical University of Vienna, Austria

Gianpaolo_Carrafiello_CIRSE_2015_Philips

Novel approches for Ablation and Embolization with ultrasound, Dual-Phase CBCT and OncoSuite

Prof. Gianpaolo Carrafiello, University of Insubria, Varese, Italy

Not able to join our lunch symposium? No problem…
Register and receive the recording.

Philips and Volcano

This year for the 1ˢᵗ time at CIRSE Philips and Volcano together are defining the future of Image Guided Therapy. Our vision is to provide integrated solutions that advance minimally invasive procedures by helping you to decide, guide and confirm the right therapy for the right patient at the point of care.

Decide

Enabling personalized treatment decisions for your patients

Guide

Simplifying complex procedures through integrated solutions that help guide the procedure.

Confirm

Help confirm excellent treatment at point of care and provide seamless documentation that the most appropriate care was given.

View Vision

Visit volcano website

OncoSuite - All Interventional Oncology in one room

Gain new clarity and risk management capabilities with OncoSuite* – the world’s first solution for embolization and ablation oncology procedures. This treatment environment can offer life-changing options for your patients.

* All features referred to are based on the Allura X-ray systems release 8.2 or higher

News

Contact information

* This field is mandatory

Country

Contact details

First name*

Last name*

Salutation

Academic title

Email address*

Phone

Company details

Company

Job title*

Specialty

State or Province

Zip or Postal Code

I hereby consent to processing of my personal data and sensitive personal data (if any) and transfer of such data abroad, in accordance with the Privacy Notice that can be found here.

What is cross border data transfer?

I agree on cross-border transfer of personal information.

I would like to receive marketing related electronic communications about Philips products, services, events, and promotions that may be relevant to me based on my user preferences and behavior. I can revoke my consent at any time.

¹ S. Miyayama et al. J Vasc Interv Radiol. 2013 Apr;24(4):501-8. doi: 10.1016/j.jvir.2012.12.022

² R. Lo_ roy, J. Geschwind et al. Radiology. 2013 Feb;266(2):636-48. doi: 10.1148/radiol.12112316